EP1278824 - Bibliographic data

CLEARANCE OF RAS-MEDIATED NEOPLASTIC CELLS FROM MIXED CELLULAR COMPOSITIONS USING REOVIRUS

Last update	18/06/2025
Legal status	Brevet déchu
Origin	Euro-PCT

(73) Holder	ONCOLYTICS BIOTECH INC. Suite 210 1167 Kensington Crescent N. W. Calgary, AB T2N 1X7 Canada
(72) Inventors	MORRIS, Donald 211 Douglasview Road, S.E. Calgary, Alberta T2Z 2S1 Canada THOMPSON, Bradley, G. 1775 - 7th Avenue N.W. Calgary, Alberta T2N 0Z5 Canada COFFEY, Matthew, C. 2231 Bowness Road, N.W. Calgary, Alberta T2N 3L4 Canada
(74) Agent	Mail recipient BARTH, RENATE ET AL Vossius & Partner Siebertstrasse 4 81675 München Allemagne

(21) Request number	EP01931251.1
(22) Request date	02/05/2001

(11) Publication number	EP1278824
Publication date	14/07/2010

(54) Title of the invention	CLEARANCE OF RAS-MEDIATED NEOPLASTIC CELLS FROM MIXED CELLULAR COMPOSITIONS USING REOVIRUS
(51) International classification	A01N 1/02, A61L 2/00, A61K 35/12, A61K 39/42, C12N 5/078
International classification (before reform)	None

Claimed priority	(31) Number: 201990 P (32) Date: 03/05/2000 (33) Country: US (31) Number: 205389 P (32) Date: 19/05/2000 (33) Country: US (31) Number: 268054 P (32) Date: 13/02/2001 (33) Country: US
Initial application	None
Divisional application	EP10007121.6 /EP2239321 None

Expected annuity	Annuity: 11 - Amount: 165 € - Due date 31/05/2011 Surtax: 11 - Amount: 33 € - Due date 01/12/2011
Last annuity	None

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2010/3, of 30/09/2010
History	Publication de la délivrance du brevet européen - Legal date 14/07/2010 Déchéance du brevet d'invention après période de grâce - Legal date 31/05/2011 Entrée en période de grâce du brevet d'invention - Legal date 31/05/2011